4543 N Stock Overview
Engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Terumo Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥391.96 |
52 Week High | JP¥391.96 |
52 Week Low | JP¥274.75 |
Beta | 0.41 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -11.52% |
5 Year Change | n/a |
Change since IPO | -4.56% |
Recent News & Updates
Recent updates
Shareholder Returns
4543 N | MX Medical Equipment | MX Market | |
---|---|---|---|
7D | 0% | 0% | 0% |
1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how 4543 N performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how 4543 N performed against the MX Market.
Price Volatility
4543 N volatility | |
---|---|
4543 N Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: 4543 N's share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine 4543 N's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1921 | n/a | Hikaru Samejima | www.terumo.com |
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts.
Terumo Corporation Fundamentals Summary
4543 N fundamental statistics | |
---|---|
Market cap | Mex$613.44b |
Earnings (TTM) | Mex$15.89b |
Revenue (TTM) | Mex$131.20b |
37.6x
P/E Ratio4.6x
P/S RatioIs 4543 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4543 N income statement (TTM) | |
---|---|
Revenue | JP¥986.67b |
Cost of Revenue | JP¥456.87b |
Gross Profit | JP¥529.80b |
Other Expenses | JP¥410.32b |
Earnings | JP¥119.49b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 80.70 |
Gross Margin | 53.70% |
Net Profit Margin | 12.11% |
Debt/Equity Ratio | 13.3% |
How did 4543 N perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield30%
Payout RatioDoes 4543 N pay a reliable dividends?
See 4543 N dividend history and benchmarksTerumo dividend dates | |
---|---|
Ex Dividend Date | Sep 27 2024 |
Dividend Pay Date | Dec 03 2024 |
Days until Ex dividend | 48 days |
Days until Dividend pay date | 19 days |
Does 4543 N pay a reliable dividends?
See 4543 N dividend history and benchmarks